|
|
|
Volumn 18, Issue 23, 2004, Pages 42-43
|
|
High-priced biotech drugs: Are they worth it?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZOPORPHYRIN DERIVATIVE;
CETUXIMAB;
BIOTECHNOLOGY;
COST;
COST EFFECTIVENESS ANALYSIS;
ECONOMIC ASPECT;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE PLANNING;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
MEDICAL ASSESSMENT;
MEDICAL INFORMATION;
MEDICARE;
NONHODGKIN LYMPHOMA;
REIMBURSEMENT;
SHORT SURVEY;
UNITED STATES;
|
|
EID: 11844256344
PISSN: 08903670
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (3)
|
|
References (0)
|
